Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

被引:0
|
作者
David A Palma
Cornelis J A Haasbeek
George B Rodrigues
Max Dahele
Michael Lock
Brian Yaremko
Robert Olson
Mitchell Liu
Jason Panarotto
GwendolynHMJ Griffioen
Stewart Gaede
Ben Slotman
Suresh Senan
机构
[1] London Regional Cancer Program,Department of Radiation Oncology
[2] VU University Medical Center,Department of Radiation Oncology
[3] British Columbia Cancer Agency,Department of Radiation Oncology
[4] Ottawa Regional Cancer Centre,Department of Radiation Oncology
来源
BMC Cancer | / 12卷
关键词
Oligometastases; Stereotactic radiotherapy; Quality of life; Cancer; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
    Tran, Phuoc T.
    Phillips, Ryan
    Shi, William
    Lim, Su Jin
    Antonarakis, Emmanuel S.
    Rowe, Steven P.
    Ross, Ashley
    Gorin, Michael A.
    Deville, Curtiland
    Greco, Stephen C.
    Paller, Channing Judith
    DeWeese, Theodore L.
    Song, Daniel Y.
    Wang, Hao
    Carducci, Michael Anthony
    Pienta, Kenneth J.
    Pomper, Martin
    Dicker, Adam P.
    Eisenberger, Mario A.
    Diehn, Maximilian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [42] A phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE).
    Phillips, Ryan
    Radwan, Noura
    Ross, Ashley
    Rowe, Steven P.
    Gorin, Michael A.
    Antonarakis, Emmanuel S.
    Deville, Curtiland
    Greco, Stephen C.
    Denmeade, Samuel R.
    Paller, Channing Judith
    Song, Daniel Y.
    Diehn, Maximilian
    Wang, Hao
    Carducci, Michael Anthony
    Pienta, Kenneth J.
    Pomper, Martin G.
    DeWeese, Theodore L.
    Dicker, Adam P.
    Eisenberger, Mario A.
    Tran, Phuoc T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
    Radwan, Noura
    Phillips, Ryan
    Ross, Ashley
    Rowe, Steven P.
    Gorin, Michael A.
    Antonarakis, Emmanuel S.
    Deville, Curtiland
    Greco, Stephen
    Denmeade, Samuel
    Paller, Channing
    Song, Daniel Y.
    Diehn, Maximilian
    Wang, Hao
    Carducci, Michael
    Pienta, Kenneth J.
    Pomper, Martin G.
    DeWeese, Theodore L.
    Dicker, Adam
    Eisenberger, Mario
    Tran, Phuoc T.
    BMC CANCER, 2017, 17
  • [44] A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
    Noura Radwan
    Ryan Phillips
    Ashley Ross
    Steven P. Rowe
    Michael A. Gorin
    Emmanuel S. Antonarakis
    Curtiland Deville
    Stephen Greco
    Samuel Denmeade
    Channing Paller
    Daniel Y. Song
    Maximilian Diehn
    Hao Wang
    Michael Carducci
    Kenneth J. Pienta
    Martin G. Pomper
    Theodore L. DeWeese
    Adam Dicker
    Mario Eisenberger
    Phuoc T. Tran
    BMC Cancer, 17
  • [45] Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
    Roge, Maximilien
    Pointreau, Yoann
    Sargos, Paul
    Meyer, Emmanuel
    Schick, Ulrike
    Hasbini, Ali
    Rio, Emmanuel
    Bera, Guillaume
    Ruffier, Amandine
    Quivrin, Magali
    Chasseray, Mathieu
    Latorzeff, Igor
    Martin, Etienne
    Guimas, Valentine
    Pommier, Pascal
    Leroy, Thomas
    Ronchin, Philippe
    Lepinoy, Alexis
    Grand, Audrey
    Cartier, Lysian
    Didas, Ossama
    Denis, Fabrice
    Libois, Vincent
    Blanc-Lapierre, Audrey
    Supiot, Stephane
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 40
  • [46] A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol
    Pryor, David
    Bressel, Mathias
    Lawrentschuk, Nathan
    Tran, Ben
    Mooi, Jennifer
    Lewin, Jeremy
    Azad, Arun
    Colyer, Duncan
    Neha, Nitika
    Shaw, Mark
    Chander, Sarat
    Neeson, Paul
    Moon, Daniel
    Cuff, Katharine
    Wood, Simon
    Murphy, Declan G.
    Sandhu, Shahneen
    Loi, Sherene
    Siva, Shankar
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 21
  • [47] Prostate cancer with oligometastatic relapse: Combining stereotactic ablative radiotherapy and durvalumab, a randomized phase II trial (POSTCARD - GETUG-P13).
    Supiot, Stephane
    Libois, Vincent
    Guimas, Valentine
    Rio, Emmanuel
    Rolland, Frederic
    Bompas, Emmanuelle
    Vansteene, Damien
    Tigreat, Marine
    Lisbona, Albert
    Colliaux, Jeremy
    Campion, Loic
    Blanc-Lapierre, Audrey
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Phase II trial of pre-operative stereotactic ablative radiotherapy (SABR) in early-stage breast cancer
    Liveringhouse, C. L.
    Diaz, R.
    Ahmed, K. A.
    Lee, M. C.
    Czerniecki, B.
    Laronga, C.
    Khakpour, N.
    Weinfurtner, R. J.
    Rosa, M.
    Montejo, M. E.
    CANCER RESEARCH, 2019, 79 (04)
  • [49] Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer.
    Hannan, Raquibul
    Christensen, Michael
    Garant, Aurelie
    Hammers, Hans J.
    Arafat, Waddah
    Courtney, Kevin Dale
    Bowman, Isaac Alex
    Cole, Suzanne
    Sher, David
    Ahn, Chul
    Timmerman, Robert D.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET
    Olson, Robert
    Abraham, Hadassah
    Leclerc, Curtis
    Benny, Alexander
    Baker, Sarah
    Matthews, Quinn
    Chng, Nick
    Bergman, Alanah
    Mou, Benjamin
    Dunne, Emma M.
    Schellenberg, Devin
    Jiang, Will
    Chan, Elisa
    Atrchian, Siavash
    Lefresne, Shilo
    Carolan, Hannah
    Valev, Boris
    Tyldesley, Scott
    Bang, Andrew
    Berrang, Tanya
    Clark, Haley
    Hsu, Fred
    Louie, Alexander V.
    Warner, Andrew
    Palma, David A.
    Howell, Doris
    Barry, Aisling
    Dawson, Laura
    Grendarova, Petra
    Walker, Debra
    Sinha, Rishi
    Tsai, Jillian
    Bahig, Houda
    Thibault, Isabelle
    Koul, Rashmi
    Senthi, Sashendra
    Phillips, Iain
    Grose, Derek
    Kelly, Paul
    Armstrong, John
    McDermott, Ronan
    Johnstone, Candice
    Vasan, Srini
    Aherne, Noel
    Harrow, Stephen
    Liu, Mitchell
    BMC CANCER, 2024, 24 (01)